Literature DB >> 6089495

An autopsy case of acute porphyria with a decrease of both uroporphyrinogen I synthetase and ferrochelatase activities.

M Yamada, M Kondo, M Tanaka, R Okeda, S Hatakeyama, T Fukui, H Tsukagoshi.   

Abstract

An autopsy case of a 37-year-old woman with acute porphyria is reported. The patient began to complain of severe menstrual pains, and later developed serious peripheral neuropathy and various autonomic nervous symptoms. The autopsy revealed a marked loss and degeneration of axons and myelin sheaths in the peripheral nervous system (PNS), and prominent central chromatolysis of the spinal anterior horn cells. The predominant process of the peripheral neuropathy appeared to be axonal degeneration. Biochemical analysis showed a marked increase of delta-aminolevulinic acid (ALA), porphobilinogen, uroporphyrin, and coproporphyrin in the urine, and an increase of coproporphyrin and protoporphyrin in the stools and blood. In the analysis of the enzymatic activities of the liver and bone narrow, the activity of ALA synthetase (ALA-S) was markedly increased, and the activities of both uroporphyrinogen I synthetase (URO-S) and ferrochelatase were decreased. It was characteristic in this case that the enzymatic abnormalities found in both acute intermittent porphyria (AIP) and variegate porphyria (VP) coexisted. Biochemical analysis of the sciatic nerve showed an increase of ALA-S activity and a decrease of both URO-S and ALA dehydrase activities. This was the first report that indicated the presence of abnormal activities of the heme biosynthetic enzymes in the peripheral nerves of porphyric patients. The possibility was discussed that these enzymatic abnormalities of the heme biosynthesis in the peripheral nerve itself might be strongly related to the pathogenesis of the porphyric neuropathy.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6089495     DOI: 10.1007/bf00695599

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  26 in total

Review 1.  Acute intermittent porphyria: clinical and selected research aspects.

Authors:  D P Tschudy; M Valsamis; C R Magnussen
Journal:  Ann Intern Med       Date:  1975-12       Impact factor: 25.391

2.  ON THE NATURE OF THE PERIPHERAL NERVE LESIONS ASSOCIATED WITH ACUTE INTERMITTENT PORPHYRIA.

Authors:  J B CAVANAGH; R S MELLICK
Journal:  J Neurol Neurosurg Psychiatry       Date:  1965-08       Impact factor: 10.154

3.  Reduced ferrochelatase activity: a defect common to porphyria variegata and protoporphyria.

Authors:  D M Becker; J D Viljoen; J Katz; S Kramer
Journal:  Br J Haematol       Date:  1977-06       Impact factor: 6.998

4.  The inhibition of red cell and brain ATPase by delta-aminolaevulinic acid.

Authors:  D Becker; D Viljoen; S Kramer
Journal:  Biochim Biophys Acta       Date:  1971-01-05

Review 5.  Acute intermittent porphyria. A clinical and biochemical study of 46 patients.

Authors:  J A Stein; D P Tschudy
Journal:  Medicine (Baltimore)       Date:  1970-01       Impact factor: 1.889

6.  The serum porphobilinogen and hepatic porphobilinogen deaminase in normal and porphyric individuals.

Authors:  K Miyagi; R Cardinal; I Bossenmaier; C J Watson
Journal:  J Lab Clin Med       Date:  1971-11

7.  Effect of delta-aminolaevulinic acid on GABA receptor binding in synaptic plasma membranes.

Authors:  M J Brennan; R C Cantrill; S Kramer
Journal:  Int J Biochem       Date:  1980

8.  Neurotoxic aspects of porphyrinopathies: lead and succinylacetone.

Authors:  E K Silbergeld; R E Hruska; D Bradley; J M Lamon; B C Frykholm
Journal:  Environ Res       Date:  1982-12       Impact factor: 6.498

9.  Alteration of activities of delta-aminolevulinic acid synthase, delta-aminolevulinic acid dehydratase and delta-aminolevulinic acid dehydratase inhibitor in the bone marrow cells of lead poisoned rats.

Authors:  M Kondo; M Kajimoto; G Urata
Journal:  Exp Hematol       Date:  1983-04       Impact factor: 3.084

10.  Studies in porphyria. IV. Expression of the gene defect of acute intermittent porphyria in cultured human skin fibroblasts and amniotic cells: prenatal diagnosis of the porphyric trait.

Authors:  S Sassa; G Solish; R D Levere; A Kappas
Journal:  J Exp Med       Date:  1975-09-01       Impact factor: 14.307

View more
  2 in total

1.  Homozygous hydroxymethylbilane synthase knock-in mice provide pathogenic insights into the severe neurological impairments present in human homozygous dominant acute intermittent porphyria.

Authors:  Makiko Yasuda; Lin Gan; Brenden Chen; Chunli Yu; Jinglan Zhang; Miguel A Gama-Sosa; Daniela D Pollak; Stefanie Berger; John D Phillips; Winfried Edelmann; Robert J Desnick
Journal:  Hum Mol Genet       Date:  2019-06-01       Impact factor: 6.150

Review 2.  Acute porphyrias - A neurological perspective.

Authors:  Lea M Gerischer; Franziska Scheibe; Astrid Nümann; Martin Köhnlein; Ulrich Stölzel; Andreas Meisel
Journal:  Brain Behav       Date:  2021-10-17       Impact factor: 2.708

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.